is an opportunistic pathogen, often associated with nosocomial infections. Ten were isolated from clinical samples during the period January 2021 and June 2022. Eight (80%) patients had cancer as a background disease and 2 patients had coronavirus disease 2019. A fatal outcome was recorded in 4 cases (40% of patients). All the isolates were susceptible to minocycline and levofloxacin. Trimethoprim/sulfamethoxazole and ceftazidime resistance rates were 20% and 40% respectively. Eight different patterns were observed by Pulsed-Field Gel Electrophoresis, only two isolates being clonally identical. The isolation of in clinical settings requires the implementation of infection prevention measures.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10323528 | PMC |
http://dx.doi.org/10.3947/ic.2023.0003 | DOI Listing |
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!